福瑞股份（300049）8月19日主力资金净流入7122.02万元

Group 1 - The core viewpoint of the article highlights the recent performance and financial metrics of Furu Pharmaceutical Co., Ltd. (福瑞股份), indicating a significant stock price increase and mixed financial results [1][3] - As of August 19, 2025, Furu's stock closed at 72.23 yuan, reflecting a 20.0% increase with a trading volume of 159,400 hands and a transaction amount of 1.127 billion yuan [1] - The company experienced a net inflow of main funds amounting to 71.22 million yuan, representing 6.32% of the total transaction amount, with notable inflows from large orders [1] Group 2 - For the first quarter of 2025, Furu reported total operating revenue of 330 million yuan, a year-on-year increase of 2.35%, while net profit attributable to shareholders decreased by 32.97% to 28.64 million yuan [1] - The company's liquidity ratios are strong, with a current ratio of 4.564 and a quick ratio of 4.141, alongside a debt-to-asset ratio of 28.99% [1] - Furu has made investments in 22 companies and participated in 552 bidding projects, showcasing its active engagement in the market [2]